High-Dose Rifampin: Shall We Be Bolder?
Am J Respir Crit Care Med
.
2018 Sep 1;198(5):558-560.
doi: 10.1164/rccm.201806-1140ED.
Author
Kelly E Dooley
1
2
Affiliations
1
1 Division of Clinical Pharmacology and.
2
2 Division of Infectious Diseases Johns Hopkins University School of Medicine Baltimore, Maryland.
PMID:
29993257
DOI:
10.1164/rccm.201806-1140ED
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antibiotics, Antitubercular*
Humans
Rifampin
Tuberculosis, Pulmonary*
Substances
Antibiotics, Antitubercular
Rifampin